Recruitment

Recruitment Status
Completed

Inclusion Criterias

Untreated stage B or C chronic lymphocytic leukemia
Untreated diffuse large B-cell lymphoma
Eligible for PET-CT
...
Untreated stage B or C chronic lymphocytic leukemia
Untreated diffuse large B-cell lymphoma
Eligible for PET-CT
Signed written informed consent
Adult over 18
The subject must be covered by a social security system

Exclusion Criterias

Weight over 120 kg
corticosteroid therapy
Age under 18
...
Weight over 120 kg
corticosteroid therapy
Age under 18
pregnant women
active infectious disease
immune hemolytic anemia
Patients concurrently included in an investigational trial
patients with creatinine clearance < 30 ml/mn

Summary

Conditions
Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
Type
Interventional
Phase
Phase 1
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Diagnostic

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criterias

Untreated stage B or C chronic lymphocytic leukemia
Untreated diffuse large B-cell lymphoma
Eligible for PET-CT
...
Untreated stage B or C chronic lymphocytic leukemia
Untreated diffuse large B-cell lymphoma
Eligible for PET-CT
Signed written informed consent
Adult over 18
The subject must be covered by a social security system

Exclusion Criterias

Weight over 120 kg
corticosteroid therapy
Age under 18
...
Weight over 120 kg
corticosteroid therapy
Age under 18
pregnant women
active infectious disease
immune hemolytic anemia
Patients concurrently included in an investigational trial
patients with creatinine clearance < 30 ml/mn

Locations

Caen, 14000
Caen, 14000

Tracking Information

NCT #
NCT02128945
Collaborators
CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France
Investigators
  • Principal Investigator: Sylvain P CHANTEPIE, MD University Hospital, Caen
  • Sylvain P CHANTEPIE, MD University Hospital, Caen